Trial NCT00845039

View at ClinicalTrials.gov 
Org. Study IDs: 13928
Secondary IDs: CP13-0708 I5A-IE-JAED NSABP FC-4

Last trial update was posted on 2018-07-02

MeSH Interventions

Antibodies, Monoclonal Cetuximab Irinotecan

MeSH Conditions

Colonic Neoplasms Rectal Neoplasms

Other Conditions

Colon Cancer Rectal Cancer

Stopping Reasons

Study terminated early 22Feb2010 with only 4 participants due to business reasons.

Limitations And Caveats

Study terminated early 22Feb2010 with only 4 participants due to business reasons. Data were collected for too few participants to draw statistically meaningful conclusions and included concerns on participant confidentiality.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID